TECHNETIUM TC99M MEDRONATE INJECTION MAY BE USED AS A BONE IMAGING AGENT TO DELINEATE AREAS OF ALTERED OSTEOGENESIS. THE FINDING OF AN ABNORMAL CONCENTRATION OF RADIOACTIVITY IMPLIES THE EXISTENCE OF UNDERLYING PATHOLOGY, BUT FURTHER STUDY IS REQUIRED TO DISTINGUISH BENIGN FROM MALIGNANT LESIONS.